A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain
NCT02656875
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
768
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Pain
Interventions
DRUG:
TRV130
Sponsor
Trevena Inc.